List of Tables
Table 1. Global Orally Inhaled Generic Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Orally Inhaled Generic Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Orally Inhaled Generic Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Orally Inhaled Generic Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Orally Inhaled Generic Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Orally Inhaled Generic Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Orally Inhaled Generic Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Orally Inhaled Generic Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Orally Inhaled Generic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Orally Inhaled Generic Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Orally Inhaled Generic Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Orally Inhaled Generic Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Orally Inhaled Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Inhaled Generic Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Orally Inhaled Generic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Orally Inhaled Generic Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Orally Inhaled Generic Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Orally Inhaled Generic Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Orally Inhaled Generic Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Orally Inhaled Generic Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Orally Inhaled Generic Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Orally Inhaled Generic Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Orally Inhaled Generic Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Orally Inhaled Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Orally Inhaled Generic Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Orally Inhaled Generic Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Orally Inhaled Generic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Orally Inhaled Generic Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Orally Inhaled Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Orally Inhaled Generic Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Orally Inhaled Generic Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Orally Inhaled Generic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Orally Inhaled Generic Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Orally Inhaled Generic Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Orally Inhaled Generic Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Orally Inhaled Generic Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Orally Inhaled Generic Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Orally Inhaled Generic Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Orally Inhaled Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Orally Inhaled Generic Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Orally Inhaled Generic Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Orally Inhaled Generic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Orally Inhaled Generic Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Orally Inhaled Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Orally Inhaled Generic Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Orally Inhaled Generic Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Orally Inhaled Generic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Orally Inhaled Generic Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Orally Inhaled Generic Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Orally Inhaled Generic Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Orally Inhaled Generic Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Orally Inhaled Generic Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Orally Inhaled Generic Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Orally Inhaled Generic Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Orally Inhaled Generic Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Orally Inhaled Generic Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Orally Inhaled Generic Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Orally Inhaled Generic Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Orally Inhaled Generic Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Orally Inhaled Generic Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Orally Inhaled Generic Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Orally Inhaled Generic Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Orally Inhaled Generic Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Orally Inhaled Generic Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Orally Inhaled Generic Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Orally Inhaled Generic Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Orally Inhaled Generic Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Orally Inhaled Generic Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. GSK Company Information
Table 71. GSK Description and Business Overview
Table 72. GSK Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. GSK Orally Inhaled Generic Drugs Product
Table 74. GSK Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. AstraZeneca Orally Inhaled Generic Drugs Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Boehringer-Ingelheim Company Information
Table 81. Boehringer-Ingelheim Description and Business Overview
Table 82. Boehringer-Ingelheim Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Boehringer-Ingelheim Orally Inhaled Generic Drugs Product
Table 84. Boehringer-Ingelheim Recent Developments/Updates
Table 85. CTTQ Company Information
Table 86. CTTQ Description and Business Overview
Table 87. CTTQ Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. CTTQ Orally Inhaled Generic Drugs Product
Table 89. CTTQ Recent Developments/Updates
Table 90. Sphsine Company Information
Table 91. Sphsine Description and Business Overview
Table 92. Sphsine Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sphsine Orally Inhaled Generic Drugs Product
Table 94. Sphsine Recent Developments/Updates
Table 95. Daphne Pharmaceutical Company Information
Table 96. Daphne Pharmaceutical Description and Business Overview
Table 97. Daphne Pharmaceutical Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Daphne Pharmaceutical Orally Inhaled Generic Drugs Product
Table 99. Daphne Pharmaceutical Recent Developments/Updates
Table 100. Jewim Pharmaceutical Company Information
Table 101. Jewim Pharmaceutical Description and Business Overview
Table 102. Jewim Pharmaceutical Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Jewim Pharmaceutical Orally Inhaled Generic Drugs Product
Table 104. Jewim Pharmaceutical Recent Developments/Updates
Table 105. CF PharmTech Company Information
Table 106. CF PharmTech Description and Business Overview
Table 107. CF PharmTech Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. CF PharmTech Orally Inhaled Generic Drugs Product
Table 109. CF PharmTech Recent Developments/Updates
Table 110. Xianju Pharmaceutical Company Information
Table 111. Xianju Pharmaceutical Description and Business Overview
Table 112. Xianju Pharmaceutical Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Xianju Pharmaceutical Orally Inhaled Generic Drugs Product
Table 114. Xianju Pharmaceutical Recent Developments/Updates
Table 115. Joincare Pharmaceutical Company Information
Table 116. Joincare Pharmaceutical Description and Business Overview
Table 117. Joincare Pharmaceutical Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Joincare Pharmaceutical Orally Inhaled Generic Drugs Product
Table 119. Joincare Pharmaceutical Recent Developments/Updates
Table 120. Hengrui Medicine Company Information
Table 121. Hengrui Medicine Description and Business Overview
Table 122. Hengrui Medicine Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Hengrui Medicine Orally Inhaled Generic Drugs Product
Table 124. Hengrui Medicine Recent Developments/Updates
Table 125. Purity Pharmaceutical Company Information
Table 126. Purity Pharmaceutical Description and Business Overview
Table 127. Purity Pharmaceutical Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Purity Pharmaceutical Orally Inhaled Generic Drugs Product
Table 129. Purity Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Orally Inhaled Generic Drugs Distributors List
Table 133. Orally Inhaled Generic Drugs Customers List
Table 134. Orally Inhaled Generic Drugs Market Trends
Table 135. Orally Inhaled Generic Drugs Market Drivers
Table 136. Orally Inhaled Generic Drugs Market Challenges
Table 137. Orally Inhaled Generic Drugs Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Orally Inhaled Generic Drugs
Figure 2. Global Orally Inhaled Generic Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Orally Inhaled Generic Drugs Market Share by Type: 2023 & 2030
Figure 4. DPI Product Picture
Figure 5. MDI Product Picture
Figure 6. NEB Product Picture
Figure 7. Global Orally Inhaled Generic Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Orally Inhaled Generic Drugs Market Share by Application: 2023 & 2030
Figure 9. Asthma
Figure 10. COPD
Figure 11. Inhalation Anesthesia
Figure 12. Others
Figure 13. Global Orally Inhaled Generic Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Orally Inhaled Generic Drugs Market Size (2019-2030) & (US$ Million)
Figure 15. Global Orally Inhaled Generic Drugs Sales (2019-2030) & (K Units)
Figure 16. Global Orally Inhaled Generic Drugs Average Price (US$/Unit) & (2019-2030)
Figure 17. Orally Inhaled Generic Drugs Report Years Considered
Figure 18. Orally Inhaled Generic Drugs Sales Share by Manufacturers in 2023
Figure 19. Global Orally Inhaled Generic Drugs Revenue Share by Manufacturers in 2023
Figure 20. Global 5 and 10 Largest Orally Inhaled Generic Drugs Players: Market Share by Revenue in Orally Inhaled Generic Drugs in 2023
Figure 21. Orally Inhaled Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. Global Orally Inhaled Generic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Orally Inhaled Generic Drugs Sales Market Share by Country (2019-2030)
Figure 24. North America Orally Inhaled Generic Drugs Revenue Market Share by Country (2019-2030)
Figure 25. United States Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Orally Inhaled Generic Drugs Sales Market Share by Country (2019-2030)
Figure 28. Europe Orally Inhaled Generic Drugs Revenue Market Share by Country (2019-2030)
Figure 29. Germany Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Orally Inhaled Generic Drugs Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Orally Inhaled Generic Drugs Revenue Market Share by Region (2019-2030)
Figure 36. China Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Orally Inhaled Generic Drugs Sales Market Share by Country (2019-2030)
Figure 44. Mexico Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Orally Inhaled Generic Drugs Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Orally Inhaled Generic Drugs Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Orally Inhaled Generic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Orally Inhaled Generic Drugs by Type (2019-2030)
Figure 53. Global Revenue Market Share of Orally Inhaled Generic Drugs by Type (2019-2030)
Figure 54. Global Orally Inhaled Generic Drugs Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Orally Inhaled Generic Drugs by Application (2019-2030)
Figure 56. Global Revenue Market Share of Orally Inhaled Generic Drugs by Application (2019-2030)
Figure 57. Global Orally Inhaled Generic Drugs Price (US$/Unit) by Application (2019-2030)
Figure 58. Orally Inhaled Generic Drugs Value Chain
Figure 59. Orally Inhaled Generic Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
